BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23436459)

  • 1. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.
    Harris JJ; McCarthy HJ; Ni L; Wherlock M; Kang H; Wetzels JF; Welsh GI; Saleem MA
    J Pathol; 2013 Apr; 229(5):660-71. PubMed ID: 23436459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
    Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
    May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
    Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
    Babayeva S; Miller M; Zilber Y; El Kares R; Bernard C; Bitzan M; Goodyer P; Torban E
    Pediatr Nephrol; 2011 Jul; 26(7):1071-81. PubMed ID: 21380797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
    Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
    Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PKGIα/VASP pathway is involved in insulin- and high glucose-dependent regulation of albumin permeability in cultured rat podocytes.
    Rachubik P; Szrejder M; Audzeyenka I; Rogacka D; Rychłowski M; Angielski S; Piwkowska A
    J Biochem; 2020 Dec; 168(6):575-588. PubMed ID: 32484874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
    Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
    Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes.
    Eroglu FK; Yazar V; Guler U; Yıldırım M; Yildirim T; Gungor T; Celikkaya E; Karakaya D; Turay N; Ciftci Dede E; Korkusuz P; Salih B; Bulbul M; Gursel I
    Am J Physiol Renal Physiol; 2021 Nov; 321(5):F659-F673. PubMed ID: 34569252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.
    Bitzan M; Babayeva S; Vasudevan A; Goodyer P; Torban E
    Pediatr Nephrol; 2012 Dec; 27(12):2217-26. PubMed ID: 22538781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.
    Sharma R; Waller AP; Agrawal S; Wolfgang KJ; Luu H; Shahzad K; Isermann B; Smoyer WE; Nieman MT; Kerlin BA
    J Am Soc Nephrol; 2017 Sep; 28(9):2618-2630. PubMed ID: 28424276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
    Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
    Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY; Roshanravan H; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vasodilator-stimulated phosphoprotein in podocyte functioning.
    Rachubik P; Piwkowska A
    Cell Biol Int; 2019 Oct; 43(10):1092-1101. PubMed ID: 30968998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes.
    Coward RJ; Foster RR; Patton D; Ni L; Lennon R; Bates DO; Harper SJ; Mathieson PW; Saleem MA
    J Am Soc Nephrol; 2005 Mar; 16(3):629-37. PubMed ID: 15659563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.